NEAT1 and laryngotracheoesophageal cleft: Clinically, co-overexpression of Oct4/NEAT1/MALAT1 emerged as an independent predictor of poor outcomes in LC patients (Huang et al., 2020[25]; Jen et al., 2017[30]; Kong et al., 2019[37]).